サマリー

エピネフリン自己注射器の世界市場 2024-2028
エピネフリン自己注射器市場は2023-2028年に24億4000万米ドル成長し、予測期間中のCAGRは10.59%で加速すると予測されます。当レポートでは、エピネフリン自己注射器市場について、市場規模や予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析など、総合的な分析を提供しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、アレルギーの有病率の増加、ベンダーによるマーケティング戦略の革新の高まり、アナフィラキシーに対する意識の高まり、革新的なエピネフリン自動注射器の入手可能性などが牽引しています。
Technavioのエピネフリン自己注射器市場は以下のように区分される：
タイプ別
- 0.30gm
- 0.15gm
- 0.50gm
エンドユーザー別
- 病院
- クリニック
- 在宅医療
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のエピネフリン自己注射器市場の成長を促進する主な理由の一つとして、ベンダーに対する政府の圧力による頻繁な製品発売を挙げている。また、エピネフリン自己注射器に関する認知度の高まりや、様々なベンダーやその他の組織が提供する患者支援プログラムの増加は、市場の大きな需要につながるでしょう。
このレポートはエピネフリン自己注射器市場を調査し、以下の調査分野をカバーしています：
- エピネフリン自己注射器市場のサイジング
- エピネフリン自己注射器市場予測
- エピネフリン自己注射器市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上させるために設計されており、これに伴い、本レポートでは、Adamis Pharmaceuticals Corp.、ALK Abello AS、Amneal Pharmaceuticals Inc.、Bausch Health Companies Inc.、BIOPROJET、Crossject、Halozyme Therapeutics Inc.、kaleo Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.を含むいくつかの主要なエピネフリン自己注射器市場ベンダーの詳細な分析を提供しています。また、エピネフリン自己注射器市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/epinephrine-autoinjector-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global epinephrine autoinjector market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global epinephrine autoinjector market 2018 - 2022 ($ billion)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 0.30gm - Market size and forecast 2023-2028
o Exhibit 34: Chart on 0.30gm - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on 0.30gm - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on 0.30gm - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on 0.30gm - Year-over-year growth 2023-2028 (%)
o 6.4 0.15gm - Market size and forecast 2023-2028
o Exhibit 38: Chart on 0.15gm - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on 0.15gm - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on 0.15gm - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on 0.15gm - Year-over-year growth 2023-2028 (%)
o 6.5 0.50gm - Market size and forecast 2023-2028
o Exhibit 42: Chart on 0.50gm - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on 0.50gm - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on 0.50gm - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on 0.50gm - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ billion)
o Exhibit 47: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 50: Chart on Comparison by End-user
o Exhibit 51: Data Table on Comparison by End-user
o 7.3 Hospitals and clinics - Market size and forecast 2023-2028
o Exhibit 52: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
o 7.4 Homecare - Market size and forecast 2023-2028
o Exhibit 56: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Homecare - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ billion)
o Exhibit 61: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Adamis Pharmaceuticals Corp.
o Exhibit 111: Adamis Pharmaceuticals Corp. - Overview
o Exhibit 112: Adamis Pharmaceuticals Corp. - Business segments
o Exhibit 113: Adamis Pharmaceuticals Corp. - Key offerings
o Exhibit 114: Adamis Pharmaceuticals Corp. - Segment focus
o 12.4 ALK Abello AS
o Exhibit 115: ALK Abello AS - Overview
o Exhibit 116: ALK Abello AS - Product / Service
o Exhibit 117: ALK Abello AS - Key offerings
o 12.5 Amneal Pharmaceuticals Inc.
o Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
o 12.6 Bausch Health Companies Inc.
o Exhibit 123: Bausch Health Companies Inc. - Overview
o Exhibit 124: Bausch Health Companies Inc. - Business segments
o Exhibit 125: Bausch Health Companies Inc. - Key news
o Exhibit 126: Bausch Health Companies Inc. - Key offerings
o Exhibit 127: Bausch Health Companies Inc. - Segment focus
o 12.7 BIOPROJET
o Exhibit 128: BIOPROJET - Overview
o Exhibit 129: BIOPROJET - Product / Service
o Exhibit 130: BIOPROJET - Key offerings
o 12.8 Crossject
o Exhibit 131: Crossject - Overview
o Exhibit 132: Crossject - Product / Service
o Exhibit 133: Crossject - Key offerings
o 12.9 Halozyme Therapeutics Inc.
o Exhibit 134: Halozyme Therapeutics Inc. - Overview
o Exhibit 135: Halozyme Therapeutics Inc. - Product / Service
o Exhibit 136: Halozyme Therapeutics Inc. - Key offerings
o 12.10 kaleo Inc.
o Exhibit 137: kaleo Inc. - Overview
o Exhibit 138: kaleo Inc. - Product / Service
o Exhibit 139: kaleo Inc. - Key offerings
o 12.11 Pfizer Inc.
o Exhibit 140: Pfizer Inc. - Overview
o Exhibit 141: Pfizer Inc. - Product / Service
o Exhibit 142: Pfizer Inc. - Key news
o Exhibit 143: Pfizer Inc. - Key offerings
o 12.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 144: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 145: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 146: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 147: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 148: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.13 Viatris Inc.
o Exhibit 149: Viatris Inc. - Overview
o Exhibit 150: Viatris Inc. - Business segments
o Exhibit 151: Viatris Inc. - Key news
o Exhibit 152: Viatris Inc. - Key offerings
o Exhibit 153: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 154: Inclusions checklist
o Exhibit 155: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 156: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 157: Research methodology
o Exhibit 158: Validation techniques employed for market sizing
o Exhibit 159: Information sources
o 13.5 List of abbreviations
o Exhibit 160: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global epinephrine autoinjector market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on 0.30gm - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on 0.30gm - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on 0.30gm - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on 0.30gm - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on 0.15gm - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on 0.15gm - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on 0.15gm - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on 0.15gm - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on 0.50gm - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on 0.50gm - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on 0.50gm - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on 0.50gm - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on End-user - Market share 2023-2028 (%)
Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ billion)
Exhibits61: Data Table on Market opportunity by End-user ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Adamis Pharmaceuticals Corp. - Overview
Exhibits112: Adamis Pharmaceuticals Corp. - Business segments
Exhibits113: Adamis Pharmaceuticals Corp. - Key offerings
Exhibits114: Adamis Pharmaceuticals Corp. - Segment focus
Exhibits115: ALK Abello AS - Overview
Exhibits116: ALK Abello AS - Product / Service
Exhibits117: ALK Abello AS - Key offerings
Exhibits118: Amneal Pharmaceuticals Inc. - Overview
Exhibits119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits120: Amneal Pharmaceuticals Inc. - Key news
Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits123: Bausch Health Companies Inc. - Overview
Exhibits124: Bausch Health Companies Inc. - Business segments
Exhibits125: Bausch Health Companies Inc. - Key news
Exhibits126: Bausch Health Companies Inc. - Key offerings
Exhibits127: Bausch Health Companies Inc. - Segment focus
Exhibits128: BIOPROJET - Overview
Exhibits129: BIOPROJET - Product / Service
Exhibits130: BIOPROJET - Key offerings
Exhibits131: Crossject - Overview
Exhibits132: Crossject - Product / Service
Exhibits133: Crossject - Key offerings
Exhibits134: Halozyme Therapeutics Inc. - Overview
Exhibits135: Halozyme Therapeutics Inc. - Product / Service
Exhibits136: Halozyme Therapeutics Inc. - Key offerings
Exhibits137: kaleo Inc. - Overview
Exhibits138: kaleo Inc. - Product / Service
Exhibits139: kaleo Inc. - Key offerings
Exhibits140: Pfizer Inc. - Overview
Exhibits141: Pfizer Inc. - Product / Service
Exhibits142: Pfizer Inc. - Key news
Exhibits143: Pfizer Inc. - Key offerings
Exhibits144: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits145: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits146: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits147: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits148: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits149: Viatris Inc. - Overview
Exhibits150: Viatris Inc. - Business segments
Exhibits151: Viatris Inc. - Key news
Exhibits152: Viatris Inc. - Key offerings
Exhibits153: Viatris Inc. - Segment focus
Exhibits154: Inclusions checklist
Exhibits155: Exclusions checklist
Exhibits156: Currency conversion rates for US$
Exhibits157: Research methodology
Exhibits158: Validation techniques employed for market sizing
Exhibits159: Information sources
Exhibits160: List of abbreviations